BioSig Technologies, Inc. (STEX)
NASDAQ: STEX · Real-Time Price · USD
6.27
0.00 (0.00%)
At close: Sep 12, 2025, 4:00 PM EDT
6.27
0.00 (0.00%)
After-hours: Sep 12, 2025, 7:56 PM EDT
Company Description
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States.
The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias.
It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale.
The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.
BioSig Technologies, Inc.
| Country | United States |
| Founded | 2009 |
| Employees | 5 |
| CEO | Karl McPhie |
Contact Details
Address: 12424 Wilshire Blvd, Suite 745 Los Angeles, California 90025 United States | |
| Phone | 203 409 5444 |
| Website | biosig.com |
Stock Details
| Ticker Symbol | STEX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
Key Executives
| Name | Position |
|---|---|
| Karl McPhie | Chief Executive Officer |
| Ferdinand Groenewald | Chief Financial Officer |